FDA Issues Warning on Ketamine Compounds

被引：0

|

作者：

Roush, Karen

机构：

来源：

AMERICAN JOURNAL OF NURSING | 2024年 / 124卷 / 01期

关键词：

D O I：

10.1097/01.NAJ.0001004888.21101.e6

中图分类号：

R47 [护理学];

学科分类号：

1011 ;

摘要：

More research is needed on their safe use in psychotherapy.

引用

收藏

页码：11 / 11

页数：1

相关论文

共 50 条

[21] FDA issues warning that paroxetine may increase the risk of birth defects
Wong, S
CNS SPECTRUMS, 2005, 10 (11) : 858 - 858
[22] FDA issues warning letters about unapproved eye disorder therapies
Reactions Weekly, 2023, 1975 (1) : 6 - 6
[23] US FDA issues warning against unapproved stem cell therapy
Reactions Weekly, 2018, 1684 (1) : 1 - 1
[24] FDA issues pioglitazone warning based on 5-year study results
Reactions Weekly, 2011, 1357 (1) : 2 - 2
[25] US FDA issues PML warning after Tecfidera-related death
Reactions Weekly, 2014, 1530 (1) : 5 - 5
[26] FDA VARICELLA WARNING
TINKELMAN, DG
PEDIATRICS, 1992, 90 (03) : 479 - 480
[27] FDA rosiglitazone warning
Kuehn, Bridget M.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (24): : 2858 - 2858
[28] FDA Warning for Etravirine
不详
JOURNAL OF DRUGS IN DERMATOLOGY, 2009, 8 (11) : 1050 - 1050
[29] FDA Azithromycin Warning
不详
MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2013, 55 (1413): : 28 - 28
[30] FDA Issues Warning of Guillain-Barré Syndrome Risk for 2 RSV Vaccines
Anderer, Samantha
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2025,

← 1 2 3 4 5 →